HCAT
NASDAQ
US
Health Catalyst, Inc - Common stock
$1,17
▲ +$0,01
(+0,86%)
Vol 411K
6
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$169.0M
ROE
-30,3%
Margin
-34,1%
D/E
46,14
Beta
1,73
52W
$2–$8
Konsensus Wall Street
15 analis · Apr 20263
Beli Kuat
4
Beli
8
Tahan
0
Jual
0
Jual Kuat
46,7%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,09 | $0,08 | $-0,01 |
| Sep 2025 | $0,06 | $0,06 | $0,00 |
| Jun 2025 | $0,03 | $0,04 | +$0,01 |
| Mar 2025 | $0,00 | $0,01 | +$0,01 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $79.6M | $79.4M | $80.7M | $76.3M | $74.7M |
| Laba Bersih | — | -$20.7M | -$23.7M | -$41.0M | -$22.2M | -$91.0M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -27.7% | -27.7% | -27.7% | -27.7% | -30.3% | -30.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -50.8% | -31.7% | -31.7% | -31.7% | -34.0% | -34.0% |
| Gross Margin | 47.7% | 46.0% | 46.0% | 46.0% | 47.5% | 47.5% |
| D/E Ratio | 44.03 | 44.03 | 44.03 | 44.03 | 46.14 | 46.14 |
| Current Ratio | 1.83 | 1.83 | 1.83 | 1.83 | 1.88 | 1.88 |
Rasio Utama
ROA (TTM)
-14,6%
P/S (TTM)
0,53
P/B
1,2
EPS (TTM)
$-1,58
CF/Share
$-1,44
Pertumbuhan Pendapatan 3T
+8,2%
52W High
$7,65
52W Low
$2,02
$2,02
Rentang 52 Minggu
$7,65
Kesehatan Keuangan
Arus Kas Bebas
$4.3M
Utang Bersih
$120.4M
Kas
$50.8M
Total Utang
$171.2M
Per tanggal Des 31, 2025
Як HCAT виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка HCAT vs аналоги Health Care
P/E
—
▼
0%
di bawah
rekan
(30,7)
vs Rekan
vs Industri
Undervalued
P/S
0,5
▼
79%
di bawah
rekan
(2,6)
vs Rekan
vs Industri
Undervalued
P/B
1,2
▼
58%
di bawah
rekan
(2,8)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,7%)
vs Rekan
vs Industri
Yield rendah
Прибутковість HCAT vs аналоги Health Care
ROE
-30,3%
▲
21%
di atas
rekan
(-38,5%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
-34,1%
▼
38%
di bawah
rekan
(-24,7%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
47,5%
▼
10%
di bawah
rekan
(52,9%)
vs Rekan
vs Industri
Lemah
ROA
-14,6%
▲
31%
di atas
rekan
(-21,2%)
vs Rekan
vs Industri
Di bawah rata-rata
Фінансове здоровʼя HCAT vs аналоги Health Care
D/E ratio
46,1
▲
139%
di atas
rekan
(19,3)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
1,9
▼
13%
di bawah
rekan
(2,2)
vs Rekan
vs Industri
Sejajar
Beta
1,7
▲
65%
di atas
rekan
(1,1)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів HCAT
HCAT
Median rekan
Industri
HCAT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
HCAT vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
LARSON-GREEN JULIE
Director · Feb 27
8361 shs
LLEWELYN LINDA
Officer · Feb 25
204695 shs
ALGER JASON
Chief Financial Officer · Feb 25
529722 shs
LANDRY BENJAMIN
General Counsel · Feb 25
305473 shs
ALBERT BENJAMIN
Chief Executive Officer · Feb 25
968833 shs
GALLAGHER DUNCAN P
Director · Feb 17
7562 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 41,18%First Light Asset Managemen…
17,55%
$14.3M
Blackrock Inc.
7,06%
$5.7M
Vanguard Group Inc
6,03%
$4.9M
Cdc Financial, Inc.
5,44%
$4.4M
Whetstone Capital Advisors,…
5,10%
$4.1M
Per tanggal Des 31, 2025